Clinical Trials List
2007-02-01 - 2009-04-30
Phase II
Terminated5
-
Trial Applicant
TTY Biopharm Company Limited
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chung-Pin Li Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wen-Chi Shen Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Tsai-Yun Chen Division of Hematology & Oncology
- Li-Tzong Chen 國衛院合作病房
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 詹昌明 Digestive System Department
- Hui-Jen Tsai Division of Hematology & Oncology
- Sheng-Fung Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
40 participants
